tirilazad
Modify Date: 2024-10-02 18:23:36
tirilazad structure
|
Common Name | tirilazad | ||
|---|---|---|---|---|
| CAS Number | 110101-67-2 | Molecular Weight | 720.96400 | |
| Density | N/A | Boiling Point | 812.9ºC at 760 mmHg | |
| Molecular Formula | C39H56N6O5S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 445.4ºC | |
Use of tirilazadTirilazad mesylate (U 74006F) is a nonglucocorticoid, 21-aminosteroid that inhibits lipid peroxidation. Tirilazad mesylate can attenuate brain or spinal cord injury caused by trauma, stroke, ischemia and reperfusion injury. Tirilazad mesylate has antiviral activities against nCoV. Tirilazad mesylate is neuroprotective for ischaemic stroke, can be used for subarachnoid hemorrhage research[1][2][3]. |
| Name | (8S,10S,13S,14S,16R,17S)-17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one,methanesulfonic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Tirilazad mesylate (U 74006F) is a nonglucocorticoid, 21-aminosteroid that inhibits lipid peroxidation. Tirilazad mesylate can attenuate brain or spinal cord injury caused by trauma, stroke, ischemia and reperfusion injury. Tirilazad mesylate has antiviral activities against nCoV. Tirilazad mesylate is neuroprotective for ischaemic stroke, can be used for subarachnoid hemorrhage research[1][2][3]. |
|---|---|
| Related Catalog | |
| References |
[1]. Bath PM, et al. Tirilazad for acute ischaemic stroke. Cochrane Database Syst Rev. 2001;(4):CD002087. |
| Boiling Point | 812.9ºC at 760 mmHg |
|---|---|
| Molecular Formula | C39H56N6O5S |
| Molecular Weight | 720.96400 |
| Flash Point | 445.4ºC |
| Exact Mass | 720.40300 |
| PSA | 135.63000 |
| LogP | 6.17600 |
| Vapour Pressure | 1.71E-26mmHg at 25°C |
| [14C]-Tirilazad mesylate |
| Freedox |
| Tirilazad mesilate (JAN) |
| UNII-19B418DV39 |
| Freedox (TN) |
| Tirilazad mesylate |